Ying Chen is an associate in the Boston office of Wilson Sonsini Goodrich & Rosati, where she advises pharmaceutical and biotech companies on intellectual property issues including patent portfolio management, filing strategies, freedom-to-operate, and patentability in all stages of the business cycle.

Ying advises clients on intellectual property issues in connection with public offerings, fundraising, in/out-licensing, acquisitions, and other partnering transactions. She works closely with companies ranging from the seed stage, clinical stage, and commercial stage, and collaborates with the companies to devise global IP strategies, including strategies focusing on platform technologies or continuous innovation of existing products. Ying also counsels investors on IP due diligence matters, analyzing the strengths and weaknesses of an IP portfolio and providing recommendations.

Ying regularly represents clients on issues relating to small molecule therapeutics, radiopharmaceuticals, peptides, drug conjugates, siRNAs, and formulations.

Prior to joining the firm, Ying was a research chemist in a specialty chemical company and was named as an inventor on seven U.S. patents on polymer compositions and formulations. She obtained her Ph.D. in organic/polymer chemistry from Penn State, wherein she focused on polymer synthesis and the design and synthesis of novel late transition metal-based organometallic catalysts.